Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onercept in Moderate to Severe Plaque Psoriasis
NCT00090129Phase 3Terminated
- Sponsor
- EMD Serono
- Start
- Sep 2004
- Primary completion
- Jun 2005
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of onercept in plaque psoriasis, sponsored by EMD Serono. Started Sep 2004; status: terminated.
02
Drugs
onercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00090129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090129.